Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HARVEY W BOWLES

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1285723718
CMS profile
285362
Location
NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$2,062.12

118 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,962.13 117
Education $99.99 1

By paying entity

PY2020 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HARVEY W BOWLES

NPI 1285723718 · CMS profile ID 285362

Allopathic & Osteopathic Physicians / Internal Medicine

NASHVILLE, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HARVEY W BOWLES, NPI 1285723718, CMS profile ID 285362. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). HARVEY W BOWLES, NPI 1285723718, CMS profile ID 285362. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
HARVEY W BOWLES, NPI 1285723718, CMS profile ID 285362, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 118 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1285723718?year=2020&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

118 matching records · $2,062.12 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 118 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 118.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $26.2108/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749011659 CMS
Lilly USA, LLC $14.6408/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728449521 CMS
Novo Nordisk Inc $21.1308/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744857341 CMS
Avion Pharmaceuticals $15.1608/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741999009 CMS
SANOFI-AVENTIS U.S. LLC $13.1008/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744110921 CMS
Novo Nordisk Inc $18.9408/13/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744832803 CMS
Amgen Inc. $13.8208/11/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741392519 CMS
Amarin Pharma Inc. $16.4108/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739896515 CMS
SANOFI-AVENTIS U.S. LLC $17.4808/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744110915 CMS
Lilly USA, LLC $15.9208/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728456233 CMS
Novo Nordisk Inc $20.1908/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744832588 CMS
Merck Sharp & Dohme Corporation $15.4907/31/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747678029 CMS
Novo Nordisk Inc $106.7107/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744880165 CMS
Novo Nordisk Inc $14.8007/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744795729 CMS
Novo Nordisk Inc $2.8407/28/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744795731 CMS
Amarin Pharma Inc. $19.1507/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739899733 CMS
Novo Nordisk Inc $5.2307/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744797175 CMS
AstraZeneca Pharmaceuticals LP $15.1907/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736337837 CMS
GlaxoSmithKline, LLC. $13.3307/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738652433 CMS
Eisai Inc. $11.9307/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 751209357 CMS
GlaxoSmithKline, LLC. $21.1607/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738830049 CMS
Astellas Pharma US Inc $22.1107/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 718302635 CMS
Novo Nordisk Inc $10.5207/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744789305 CMS
Merck Sharp & Dohme Corporation $18.3706/26/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747633579 CMS
Lilly USA, LLC $16.3906/25/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 728442767 CMS
Novo Nordisk Inc $2.0606/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744749465 CMS
Novo Nordisk Inc $1.3106/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744749467 CMS
Novo Nordisk Inc $13.7706/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744749471 CMS
Amgen Inc. $14.0206/18/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741074857 CMS
AstraZeneca Pharmaceuticals LP $15.1906/17/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736295943 CMS
Amarin Pharma Inc. $10.8206/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739899731 CMS
Novo Nordisk Inc $14.1406/08/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744746149 CMS
SANOFI-AVENTIS U.S. LLC $16.0006/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744110899 CMS
AstraZeneca Pharmaceuticals LP $14.6206/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735997517 CMS
Amarin Pharma Inc. $13.5005/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739896497 CMS
AstraZeneca Pharmaceuticals LP $14.8805/21/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 736164753 CMS
Novo Nordisk Inc $16.4905/19/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744697233 CMS
Zyla Life Sciences, Inc. $13.4505/16/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 749056707 CMS
GlaxoSmithKline, LLC. $23.0705/15/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738510415 CMS
Amgen Inc. $13.8205/14/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 741074853 CMS
GlaxoSmithKline, LLC. $12.5005/06/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738509267 CMS
Novo Nordisk Inc $12.3405/04/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744681781 CMS
SANOFI-AVENTIS U.S. LLC $11.7204/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744110893 CMS
Novo Nordisk Inc $11.8804/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744688319 CMS
Novo Nordisk Inc $16.8304/07/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744659679 CMS
AstraZeneca Pharmaceuticals LP $14.4604/03/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 735902639 CMS
Amarin Pharma Inc. $19.3103/27/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739983891 CMS
GlaxoSmithKline, LLC. $12.5003/12/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 738510079 CMS
Novo Nordisk Inc $14.7103/10/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 744642235 CMS
Amarin Pharma Inc. $14.6403/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739899735 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,071.43 163
PY2020 $2,062.12 118
PY2021 $2,492.74 137
PY2022 $1,965.95 102
PY2023 $1,710.92 86
PY2024 $1,305.97 69
PY2025 $829.72 35

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $108,005.05 10
PY2024 Principal investigator $63,829.74 8
PY2023 Principal investigator $17,275.00 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $3,000.00 11/04/2025 Non-covered Recipient Entity
Alliance for Multispecialty Research LLC
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 3 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 1228728561
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,588.00 10/24/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH
a phase third,randomised,double blind,placebo controlled,eventdriven study to evaluate the effect of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on the risk of incident heart failure and cardiovascular death in participants with increased risk of reveloping heart failure No dispute reported 06/30/2026 1185538627
Principal investigator 1 Ionis Pharmaceuticals, Inc. $500.00 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788129
Principal investigator 1 Ionis Pharmaceuticals, Inc. $575.00 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788133
Principal investigator 1 Ionis Pharmaceuticals, Inc. $1,725.00 10/08/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
IS354CS9 No dispute reported 06/30/2026 1246788137
Principal investigator 1 Teva Pharmaceuticals USA, Inc. $179.90 06/18/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH LLC
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma No dispute reported 06/30/2026 1244048664
Principal investigator 1 AstraZeneca Pharmaceuticals LP $5,900.00 06/06/2025 Non-covered Recipient Entity
ALLIANCE FOR MULTISPECIALTY RESEARCH
A Phase 3 Randomized Open label Study to Assess the Immunogenicity and Safety of IVX A12 when Co-administered with a licensed influenza vaccine No dispute reported 06/30/2026 1185538629
Principal investigator 1 PFIZER INC. $5,000.00 02/14/2025 Non-covered Recipient Entity
Alliance for Multispecialty Research LLC
A PHASE 3 RANDOMIZED OBSERVERBLINDED STUDY TO EVALUATE THE EFFICACY SAFETY TOLERABILITY AND IMMUNOGENICITY OF A MODIFIED RNA VACCINE AGAINST INFLUENZA IN HEALTHY INDIVIDUALS 18 THROUGH 64 YEARS OF AGE No dispute reported 06/30/2026 1228751080
Principal investigator 1 PFIZER INC. $15,600.00 02/06/2025 Non-covered Recipient Entity
Alliance for Multispecialty Research LLC
AN INTERVENTIONAL EFFICACY AND SAFETY PHASE 3 DOUBLEBLIND 2ARM STUDY TO INVESTIGATE ORALLY ADMINISTERED IBUZATRELVIR COMPARED WITH PLACEBO IN NONHOSPITALIZED SYMPTOMATIC ADULT AND ADOLESCENT PARTICIPANTS WITH COVID19 WHO ARE AT HIGH RISK OF PROGRESSING TO SEVERE ILLNESS No dispute reported 06/30/2026 1228757316
Principal investigator 1 VERTEX PHARMACEUTICALS INCORPORATED $62,937.15 01/01/2025 Non-covered Recipient Entity
AMR NASHVILLE TN
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-design Study of the Efficacy and Safety of Suzetrigine in Subjects With Painful Diabetic Peripheral Neuropathy No dispute reported 06/30/2026 1214125206